SCHEMBL19904660

SCHEMBL19904660

Cc1cc(CCN2CCC2)ccc1OC1CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.46
SIGMAR1 Q99720 5/20 0.44
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PDE4B Q07343 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
SMPD1 P17405 1/20 0.41
MBTD1 Q05BQ5 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EBP Q15125 2/20 0.40
MAPT P10636 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21122862 0.92 ABCB1 (0.46) HRH3SIGMAR1L3MBTL3L3MBTL1EBP
SCHEMBL24045454 0.89 HRH1 (0.47) HRH3SIGMAR1KCNH2SMN1; SMN2L3MBTL3
SCHEMBL16596049 0.76 SLC6A4 (0.48) HRH3SIGMAR1KCNH2L3MBTL3L3MBTL1
SCHEMBL16695091 0.76 CSNK2A1 (0.53) HRH3SIGMAR1KCNH2TMEM97
SCHEMBL18634962 0.74 ALDH1A1 (0.40) SMN1; SMN2PDE4BMAPTCRHBPCRHR2
SCHEMBL19904416 0.74 ABCB1 (0.44) HRH3SIGMAR1KCNH2L3MBTL3L3MBTL1
SCHEMBL16595882 0.73 SLC6A4 (0.51) HRH3SIGMAR1KCNH2L3MBTL3L3MBTL1
SCHEMBL16595899 0.73 CSNK2A1 (0.53) HRH3SIGMAR1KCNH2TMEM97
SCHEMBL19904479 0.73 HRH3 (0.45) HRH3SIGMAR1KCNH2EBPTMEM97
SCHEMBL19904403 0.72 ALDH1A1 (0.36) KCNH2SMN1; SMN2PDE4BMAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed